Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Cross Below 200 Day Moving Average – Should You Sell?

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $11.83 and traded as low as $11.20. Ono Pharmaceutical shares last traded at $11.20, with a volume of 7,370 shares.

Ono Pharmaceutical Stock Up 13.1 %

The firm’s 50-day simple moving average is $10.06 and its two-hundred day simple moving average is $11.81. The company has a debt-to-equity ratio of 0.14, a current ratio of 3.55 and a quick ratio of 2.80. The company has a market capitalization of $5.26 billion, a price-to-earnings ratio of 10.76 and a beta of 0.59.

Ono Pharmaceutical (OTCMKTS:OPHLF) last released its quarterly earnings results on Monday, February 3rd. The company reported $0.21 earnings per share for the quarter. Ono Pharmaceutical had a return on equity of 9.10% and a net margin of 15.15%.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.